Justices Told FDA's 'Smoking Gun' Sinks Fosamax MDL
By Bill Wichert ( September 14, 2018, 7:55 PM EDT) -- Merck Sharp & Dohme Corp. has told the U.S. Supreme Court that "smoking gun" evidence from the U.S. Food and Drug Administration should sink a Third Circuit decision reviving multidistrict litigation over the company's alleged failure to warn about a risk of femoral fractures from its osteoporosis drug Fosamax....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.